Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals
Authors:
- 26 December 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 64 (7) , 839-844
Abstract
The rapid emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) represents a major public health threat, including in the long-term acute care hospital (LTACH) setting. Our objective in this study was to describe the epidemiologic characteristics of CRKP in a network of US LTACHs. An observational study was performed among 64 LTACHs from January 2014 to March 2015. Clinical cultures were included, with the first CRKP isolate recovered from each patient per study quarter evaluated. LTACH and geographic area–based CRKP prevalence and clinical and microbiologic characteristics were described. A total of 3846 K. pneumoniae cultures were identified, with an overall carbapenem resistance rate of 24.6%. There were significant differences in CRKP rates across geographic regions, with the highest in the West (42.2%). Of 946 CRKP isolates, 507 (53.6%) were from a respiratory source, 350 (37.0%) from a urinary source, and 9 (9.4%) from blood. Among 821 unique patients with CRKP colonization or infection, the median age was 73 years. There was a high prevalence of respiratory failure (39.8%) and the presence of a central venous catheter (50.9%) or tracheostomy (64.8%). Resistance rates of CRKP isolates were high for amikacin (59.2%) and fluoroquinolones (>97%). The resistance rate to colistin/polymyxin B was 16.1%. Nearly 25% of K. pneumoniae clinical isolates in a US network of LTACHs were CRKP. Expansion of national surveillance efforts and improved communication among LTACHs and acute care hospitals will be critical for reducing the continued emergence of CRKP across the healthcare continuum.Keywords
This publication has 17 references indexed in Scilit:
- Prevention of Colonization and Infection by Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae in Long-term Acute-Care HospitalsClinical Infectious Diseases, 2014
- Faculty Opinions recommendation of Vital signs: carbapenem-resistant Enterobacteriaceae.2014
- Deaths Attributable to Carbapenem-ResistantEnterobacteriaceaeInfectionsEmerging Infectious Diseases, 2014
- Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional NetworkAntimicrobial Agents and Chemotherapy, 2014
- The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase–Producing EnterobacteriaceaeClinical Infectious Diseases, 2013
- Emergence and Rapid Regional Spread of Klebsiella pneumoniae Carbapenemase-Producing EnterobacteriaceaeClinical Infectious Diseases, 2011
- Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09Journal of Antimicrobial Chemotherapy, 2011
- Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)Diagnostic Microbiology and Infectious Disease, 2009
- Long‐Term Acute Care HospitalsClinical Infectious Diseases, 2009
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteriaThe Lancet Infectious Diseases, 2009